Nursing Elites

1. What should a healthcare professional monitor in a patient receiving insulin who is at risk for hypoglycemia?

• A. Monitor blood glucose levels
• B. Monitor for respiratory distress
• C. Monitor for muscle weakness
• D. Monitor for hyperkalemia

Correct answer: A

Rationale: Monitoring blood glucose levels is crucial in patients receiving insulin who are at risk for hypoglycemia. Insulin can lower blood sugar levels, potentially leading to hypoglycemia, which can be harmful if not promptly recognized and managed. Checking blood glucose levels allows for early detection of low blood sugar levels, enabling timely interventions to prevent complications. Choices B, C, and D are incorrect as they do not directly relate to monitoring for hypoglycemia in patients receiving insulin.

2. Which ECG change is associated with hyperkalemia?

• A. Flattened T waves
• B. Prominent U waves
• C. Elevated ST segments
• D. Widened QRS complex

Correct answer: A

Rationale: Flattened T waves are a characteristic ECG change seen in hyperkalemia. Hyperkalemia affects the repolarization phase of the cardiac cycle, leading to T wave abnormalities. Prominent U waves are typically seen in hypokalemia. Elevated ST segments are more indicative of myocardial infarction or pericarditis. Widened QRS complexes are commonly associated with conditions like bundle branch blocks or certain toxicities.

3. What is the first medication to give for wheezing due to an allergic reaction?

• A. Albuterol via nebulizer
• B. Cromolyn 20 mg via nebulizer
• C. Methylprednisolone 100 mg IV
• D. Aminophylline 500 mg IV

Correct answer: A

Rationale: Albuterol is the first-line medication for treating wheezing due to an allergic reaction. Albuterol is a short-acting beta-agonist that helps relieve bronchospasm quickly. Cromolyn is more commonly used for the prevention of asthma symptoms rather than for acute treatment. Methylprednisolone and aminophylline are not the first-line medications for acute wheezing due to an allergic reaction.

4. What are the dietary instructions for a patient with pre-dialysis end-stage kidney disease?

• A. Increase protein intake
• B. Reduce sodium intake
• C. Reduce potassium intake
• D. Restrict protein intake to 0.55-0.60 g/kg/day

Correct answer: D

Rationale: The correct answer is to restrict protein intake to 0.55-0.60 g/kg/day for a patient with pre-dialysis end-stage kidney disease. Excessive protein intake can worsen kidney function in such patients. Increasing protein intake, as mentioned in choice A, is not recommended due to the strain it puts on the kidneys. While reducing sodium intake, as in choice B, is relevant for managing blood pressure, it is not specifically related to pre-dialysis end-stage kidney disease. Choice C, reducing potassium intake, is important for patients with kidney disease, but it is not the primary dietary instruction for those with pre-dialysis end-stage kidney disease.

5. What are the manifestations of osteomyelitis?

• A. Localized pain, swelling, erythema
• B. Elevated white blood cells
• C. Elevated calcium levels
• D. Low potassium levels

Correct answer: A

Rationale: Osteomyelitis often manifests as localized pain, swelling, and erythema due to infection in the bone. These symptoms are characteristic of inflammation and infection in the bone tissue. Elevated white blood cells (Choice B) may be present as part of the body's immune response to the infection but are not specific manifestations of osteomyelitis. Elevated calcium levels (Choice C) and low potassium levels (Choice D) are not typically associated with osteomyelitis.

Similar Questions